All posts by: Michael Zand

About Michael Zand

Sam’s stem cell treatment – can you help Ballymena boy? – Ballymena Times

Continue reading

2015-11-28

Ballymena Times

Sam’s stem cell treatment – can you help Ballymena boy?
Ballymena Times
“Recently my mother was contacted and told that Sam was selected to receive stem cell treatment but it was not covered by the NHS because the procedure is carried out in America. “This treatment has had over an 82% success rating and works by replacing …

Continue reading

2015-11-28

Belfast Telegraph

Ulster University joins in hunt for stem cell donor who could help save little
Belfast Telegraph
As only 60% of those in need of a blood stem cell donation find a donor with a perfectly matching tissue-type, Alara’s parents and Delete Blood Cancer UK are continuing to appeal for people to register as potential donors to increase the chances of
Brave Alara inspires Ulster University to host event in a bid to find her a Belfast Live

all 2 news articles »

Continue reading

2015-11-28

Next Big Future

Editing sperm stem cells could be the safest approach to genetically editing
Next Big Future
The way Li’s team did it was to avoid embryos, and instead edit “spermatogonial” stem cells growing in his lab. These are the factory cells that make sperm. By gene editing mouse sperm cells first, and then using corrected sperm to make embryos, Li’s

Continue reading

2015-11-27

Medical Xpress

New target could eliminate lurking cancer stem cells
Medical Xpress
Scientists from Trinity College Dublin have identified a novel target that could help to identify ‘cancer stem cells‘ while they are in their inactive state. The scientists could then jolt these cells into action so that they could be eliminated by

and more »

Continue reading

2015-11-27

Mesoblast’s mesenchymal stem cell product receives favorable reimbursement in
Seeking Alpha
Regenerative medicine firm Mesoblast (NASDAQ:MESO) announces that Japan’s National Health Service has established reimbursement for its TEMCELL (MSC-100-IV) mesenchymal stem cell product for the treatment of acute graft versus host disease …
Mesoblast Plans February Launch Of Stem Cell Product TEMCELL in Japan (NASDAQ The Articlebasis.com
Mesoblast’s Japan Licensee Receives Pricing for TEMCELL® HS Inj. for Treatment GlobeNewswire (press release)
Is Selling Mesoblast limited (ADR) Here a Winning Strategy?FinancialMagazin.com

all 7 news articles »